We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
232 hedge funds and large institutions have $3.73B invested in Acadia Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 76 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
32% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 22
20% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 76
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
2% more funds holding
Funds holding: 227 → 232 (+5)
3% more capital invested
Capital invested by funds: $3.61B → $3.73B (+$121M)
3% less call options, than puts
Call options by funds: $41.1M | Put options by funds: $42.5M
Holders
232
Holders Change
+5
Holders Change %
+2.2%
% of All Funds
6.19%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.19%
New
29
Increased
91
Reduced
76
Closed
22
Calls
$41.1M
Puts
$42.5M
Net Calls
-$1.34M
Net Calls Change
-$15.5M
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$44.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$38.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$29.6M |
| 4 |
Goldman Sachs
New York
|
+$28.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$28.2M |
